flecainide has been researched along with Fetal Death in 5 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
Fetal Death: Death of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fourteen mothers were treated with flecainide for fetal atrial tachycardias associated with intrauterine cardiac failure." | 7.68 | Flecainide in the treatment of fetal tachycardias. ( Allan, LD; Chita, SK; Maxwell, D; Priestley, K; Sharland, GK, 1991) |
| "Fourteen mothers were treated with flecainide for fetal atrial tachycardias associated with intrauterine cardiac failure." | 3.68 | Flecainide in the treatment of fetal tachycardias. ( Allan, LD; Chita, SK; Maxwell, D; Priestley, K; Sharland, GK, 1991) |
| "Standardized treatment of fetal tachyarrhythmia has not been established." | 2.90 | Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial. ( Hagiwara, A; Hamasaki, T; Horigome, H; Ikeda, T; Inamura, N; Kato, H; Katsuragi, S; Kawataki, M; Maeno, Y; Miyoshi, T; Nii, M; Sago, H; Sakaguchi, H; Shimizu, W; Shiraishi, I; Taketazu, M; Ueda, K; Yamamoto, H; Yasukochi, S; Yoda, H, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyoshi, T | 2 |
| Maeno, Y | 2 |
| Hamasaki, T | 2 |
| Inamura, N | 2 |
| Yasukochi, S | 2 |
| Kawataki, M | 2 |
| Horigome, H | 2 |
| Yoda, H | 2 |
| Taketazu, M | 2 |
| Nii, M | 2 |
| Hagiwara, A | 2 |
| Kato, H | 2 |
| Shimizu, W | 2 |
| Shiraishi, I | 2 |
| Sakaguchi, H | 2 |
| Ueda, K | 2 |
| Katsuragi, S | 2 |
| Yamamoto, H | 2 |
| Sago, H | 2 |
| Ikeda, T | 2 |
| Shozu, M | 1 |
| Kohl, T | 1 |
| Tercanli, S | 1 |
| Kececioglu, D | 1 |
| Holzgreve, W | 1 |
| Azancot-Benisty, A | 1 |
| Areias, JC | 1 |
| Oberhänsli, I | 1 |
| Schmidt, KG | 1 |
| Tulzer, G | 1 |
| Viart, P | 1 |
| Allan, LD | 1 |
| Chita, SK | 1 |
| Sharland, GK | 1 |
| Maxwell, D | 1 |
| Priestley, K | 1 |
1 trial available for flecainide and Fetal Death
| Article | Year |
|---|---|
Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial.
Topics: Administration, Oral; Adult; Anti-Arrhythmia Agents; Atrial Flutter; Cesarean Section; Digoxin; Fema | 2019 |
4 other studies available for flecainide and Fetal Death
| Article | Year |
|---|---|
Antenatal antiarrhythmic treatment for fetal tachyarrhythmias: a study protocol for a prospective multicentre trial.
Topics: Anti-Arrhythmia Agents; Atrial Flutter; Child Development; Child, Preschool; Digoxin; Drug Therapy, | 2017 |
Direct fetal administration of adenosine for the termination of incessant supraventricular tachycardia.
Topics: Adenosine; Digoxin; Female; Fetal Death; Flecainide; Gestational Age; Heart Rate; Humans; Hydrops Fe | 1995 |
[European protocol for the management of fetal supraventricular tachycardia. European Association of Pediatric Cardiology].
Topics: Anti-Arrhythmia Agents; Digoxin; Drug Therapy, Combination; Electrocardiography; Female; Fetal Death | 1997 |
Flecainide in the treatment of fetal tachycardias.
Topics: Cardiac Output, Low; Digoxin; Female; Fetal Death; Fetal Diseases; Flecainide; Humans; Pregnancy; Ta | 1991 |